ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs

May 30, 1980

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988